chr11-111357645-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006235.3(POU2AF1):c.256G>A(p.Gly86Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000521 in 1,613,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006235.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POU2AF1 | NM_006235.3 | c.256G>A | p.Gly86Ser | missense_variant | 4/5 | ENST00000393067.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POU2AF1 | ENST00000393067.8 | c.256G>A | p.Gly86Ser | missense_variant | 4/5 | 1 | NM_006235.3 | P1 | |
POU2AF1 | ENST00000531398.1 | c.262G>A | p.Gly88Ser | missense_variant | 5/5 | 4 | |||
POU2AF1 | ENST00000525584.1 | n.375G>A | non_coding_transcript_exon_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 248764Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134844
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461390Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 726978
GnomAD4 genome AF: 0.000230 AC: 35AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.256G>A (p.G86S) alteration is located in exon 4 (coding exon 4) of the POU2AF1 gene. This alteration results from a G to A substitution at nucleotide position 256, causing the glycine (G) at amino acid position 86 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at